Niagen Bioscience, Inc. (NAGE)
5.02
+0.16
(+3.29%)
USD |
NASDAQ |
Feb 23, 16:00
5.15
+0.13
(+2.59%)
After-Hours: 04:16
Niagen Bioscience Total Assets (Quarterly) : 98.14M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 823.61M |
| Nephros, Inc. | 13.25M |
| Harrow, Inc. | 363.07M |
| Astrana Health, Inc. | 2.237B |
| Clover Health Investments Corp. | 559.66M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.46M |
| Shareholders Equity (Quarterly) | 70.68M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 4.122 |
| Net Debt Paydown Yield | 0.00% |